Riccardo Canevari

Company: RadioPharm Theranostics

Job title: CEO

Seminars:

Panel Discussion: Phase 0 for Radiopharmaceuticals: Benefits & Risks 12:00 pm

Uncovering the rationale behind conducting these preliminary studies Exploring the pharmacokinetic and pharmacodynamic data it can provide Considerations for initiating a phase 0 trialRead more

day: P&T Track AM